Prognostic factors and evaluation of a clinical score for predicting survival after resection of colorectal liver metastases

Liver International

Volumn 29, Issue 1, 2009, Pages 89-102

  Konopke, Ralf ^a   Kersting, Stephan ^a   Distler, Marius ^a   Dietrich, Jeannine ^a   Gastmeier, Jörg ^a   Heller, Axel ^a   Kulisch, Eberhard ^a   Saeger, Hans Detlev ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Colorectal carcinoma; Liver metastases; Prognostic factors; Risks tratification; Survival

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTION; PROGNOSIS; RISK ASSESSMENT; SCORING SYSTEM; SURGICAL TECHNIQUE;

COLORECTAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; PROGNOSIS; RESEARCH DESIGN; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 57749183889     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01845.x     Document Type: Article

References (48)

1. Foster JH. Survival after liver resection for secondary tumors. Am J Surg 1978; 135: 389-94.
2. Levine AW, Donegan WL, Irwin M. Adenocarcinoma of the colon with hepatic metastases. Fifteen-year survival. JAMA 1982; 247: 2809-10.
3. Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet 1994; 343: 1405-10.
4. Nakamura S, Suzuki S, Baba S. Resection of liver metastases of colorectal carcinoma. World J Surg 1997; 21: 741-7.
5. Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 1996; 77: 1254-62.
6. Scheele J, Altendorf-Hofmann A, Grube T, Hohenberger W, Stangl R, Schmidt K. Resection of colorectal liver metastases. What prognostic factors determine patient selection? Chirurg 2001; 72: 547-60.
7. Folprecht G, Grothey A, Alberts S, Raab HR, Kohne CH. Neoadjuvant treatment of unresectable colorectal liver metastases: Correlation between tumour response and resection rates. Ann Oncol 2005; 16: 1311-9.
8. Geoghegan JG, Scheele J. Treatment of colorectal liver metastases. Br J Surg 1999; 86: 158-69.
9. Rosen SA, Buell JF, Yoshida A, et al. Initial presentation with stage IV colorectal cancer: How aggressive should we be? Arch Surg 2000; 135: 530-4; discussion 34-5.
10. Malafosse R, Penna C, Sa Cunha A, Nordlinger B. Surgical management of hepatic metastases from colorectal malignancies. Ann Oncol 2001; 12: 887-94.
11. Lahr CJ, Soong SJ, Cloud G, Smith JW, Urist MM, Balch CM. A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma. J Clin Oncol 1983; 1: 720-6.
12. Tomlinson JS, Jarnagin WR, Dematteo RP, et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 2007; 25: 4575-80.
13. Cummings LC, Payes JD, Cooper GS. Survival after hepatic resection in metastatic colorectal cancer: A population-based study. Cancer 2007; 109: 718-26.
14. Ercolani G, Grazi GL, Ravaioli M, et al. Liver resection for multiple colorectal metastases: Influence of parenchymal involvement and total tumor volume, vs number or location, on long-term survival. Arch Surg 2002; 137: 1187-92.
15. Grazi GL, Mazziotti A, Jovine E, et al. Total vascular exclusion of the liver during hepatic surgery. Selective use, extensive use, or abuse? Arch Surg 1997; 132: 1104-9.
16. Mann CD, Neal CP, Pattenden CJ, et al. Major resection of hepatic colorectal liver metastases in elderly patients - an aggressive approach is justified. Eur J Surg Oncol 2007; 34: 428-32.
17. Minagawa M, Makuuchi M, Torzilli G, et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: Long-term results. Ann Surg 2000; 231: 487-99.
18. Elias D, Cavalcanti A, Sabourin JC, Pignon JP, Ducreux M, Lasser P. Results of 136 curative hepatectomies with a safety margin of less than 10 mm for colorectal metastases. J Surg Oncol 1998; 69: 88-93.
19. Hamady ZZ, Cameron IC, Wyatt J, Prasad RK, Toogood GJ, Lodge JP. Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: A critical appraisal of the 1cm rule. Eur J Surg Oncol 2006; 32: 557-63.
20. Pawlik TM, Scoggins CR, Zorzi D, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005; 241: 715-22; discussion 22-4.
21. Hoelscher TJ, Mccall WV, Powell J, Marsh GR, Erwin CW. Two methods of scoring sleep with the Oxford Medilog 9000: Comparison to conventional paper scoring. Sleep 1989; 12: 133-9.
22. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995; 19: 59-71.
23. Hao CY, Ji JF. Surgical treatment of liver metastases of colorectal cancer: Strategies and controversies in 2006. Eur J Surg Oncol 2006; 32: 473-83.
24. Scheele J, Altendorf-Hofmann A. Resection of colorectal liver metastases. Langenbecks Arch Surg 1999; 384: 313-27.
25. De Santibanes E, Lassalle FB, Mccormack L, et al. Simultaneous colorectal and hepatic resections for colorectal cancer: Postoperative and longterm outcomes. J Am Coll Surg 2002; 195: 196-202.
26. Martin R, Paty P, Fong Y, et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 2003; 197: 233-41; discussion 41-2.
27. Bismuth H, Castaing D, Traynor O. Surgery for synchronous hepatic metastases of colorectal cancer. Scand J Gastroenterol 1988; 149(Suppl.): 144-9.
28. Cady B, Jenkins RL, Steele GD Jr., et al. Surgical margin in hepatic resection for colorectal metastasis: A critical and improvable determinant of outcome. Ann Surg 1998; 227: 566-71.
29. Lambert LA, Colacchio TA, Barth RJ Jr. Interval hepatic resection of colorectal metastases improves patient selection. Arch Surg 2000; 135: 473-9; discussion 79-80.
30. Yan TD, Chu F, Black D, King DW, Morris DL. Synchronous resection of colorectal primary cancer and liver metastases. World J Surg 2007; 31: 1496-501.
31. Capussotti L, Vigano L, Ferrero A, Lo Tesoriere R, Ribero D, Polastri R. Timing of resection of liver metastases synchronous to colorectal tumor: proposal of prognosis-based decisional model. Ann Surg Oncol 2007; 14: 1143-50.
32. Lee WS, Kim MJ, Yun SH, et al. Risk factor stratification after simultaneous liver and colorectal resection for synchronous colorectal metastasis. Langenbecks Arch Surg 2008; 393: 13-9.
33. Gayowski TJ, Iwatsuki S, Madariaga JR, et al. Experience in hepatic resection for metastatic colorectal cancer: Analysis of clinical and pathologic risk factors. Surgery 1994; 116: 703-10; discussion 10-1.
34. Malik HZ, Hamady ZZ, Adair R, et al. Prognostic influence of multiple hepatic metastases from colorectal cancer. Eur J Surg Oncol 2007; 33: 468-73.
35. Imamura H, Kawasaki S. Treatment strategy for multiple hepatic metastases of colorectal carcinoma. J Hepatobiliary Pancreat Surg 1999; 6: 23-9.
36. Shimada H, Tanaka K, Masui H, et al. Results of surgical treatment for multiple (> or = 5 nodules) bi-lobar hepatic metastases from colorectal cancer. Langenbecks Arch Surg 2004; 389: 114-21.
37. Malik HZ, Prasad KR, Halazun KJ, et al. Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg 2007; 246: 806-14.
38. Goldstein MJ, Mitchell EP. Carcino-embryonic antigen in the staging and follow-up of patients with colorectal cancer. Cancer Invest 2005; 23: 338-51.
39. Aldrighetti L, Castoldi R, Di Palo S, et al. Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases. Chir Ital 2005; 57: 555-70.
40. Cheng SH, Horng CF, Clarke JL, et al. Prognostic index score and clinical prediction model of local regional recurrence after mastectomy in breast cancer patients. Int J Radiat Oncol Biol Phys 2006; 64: 1401-9.
41. Thompson IM, Ankerst DP, Chi C, et al. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. J Natl Cancer Inst 2006; 98: 529-34.
42. Zorzi D, Laurent A, Pawlik TM, Lauwers GY, Vauthey JN, Abdalla EK. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 2007; 94: 274-86.
43. Karoui M, Penna C, Amin-Hashem M, et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006; 243: 1-7.
44. Behrns KE, Tsiotos GG, Desouza NF, Krishna MK, Ludwig J, Nagorney DM. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 1998; 2: 292-8.
45. Azoulay D, Castaing D, Smail A, et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 2000; 231: 480-6.
46. Fernandez FG, Ritter J, Goodwin JW, Linehan DC, Hawkins WG, Strasberg SM. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg 2005; 200: 845-53.
47. Bipat S, Van Leeuwen MS, Comans EF, et al. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis-meta-analysis. Radiology 2005; 237: 123-31.
48. Konopke R, Kersting S, Bergert H, et al. Contrast-enhanced ultrasonography to detect liver metastases: A prospective trial to compare transcutaneous unenhanced and contrast-enhanced ultrasonography in patients undergoing laparotomy. Int J Colorectal Dis 2007; 22: 201-7.